|
ATE428733T1
(de)
|
2000-03-14 |
2009-05-15 |
Unilever Nv |
Variabele domänen der schweren kette eines antikörpers gegen menschliche ernährungslipasen und deren verwendungen
|
|
JP4213586B2
(ja)
*
|
2001-09-13 |
2009-01-21 |
株式会社抗体研究所 |
ラクダ抗体ライブラリーの作製方法
|
|
WO2003055527A2
(en)
*
|
2002-01-03 |
2003-07-10 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
Immunoconjugates useful for treatment of tumours
|
|
CA2472927A1
(en)
|
2002-01-10 |
2003-07-17 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
A novel splice variant of myd88 and uses thereof
|
|
NZ540194A
(en)
|
2002-11-08 |
2008-07-31 |
Ablynx Nv |
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
|
|
EP1558645B1
(de)
|
2002-11-08 |
2011-07-27 |
Ablynx N.V. |
Stabilisierte einzel-domänen-antikörper in einer pharmazeutischen zusammensetzung ausgestaltet für inhalation
|
|
PT1687338E
(pt)
|
2003-11-07 |
2011-01-20 |
Ablynx Nv |
Anticorpos de domínio único vhh de camelídeos direccionados para o receptor do factor de crescimento epidérmico e suas utilizações
|
|
US7785903B2
(en)
|
2004-04-09 |
2010-08-31 |
Genentech, Inc. |
Variable domain library and uses
|
|
KR20070084069A
(ko)
|
2004-10-08 |
2007-08-24 |
도만티스 리미티드 |
Ｔｎｆｒ1에 대한 단일 도메인 항체 및 이의 사용 방법
|
|
SI1836500T1
(sl)
|
2005-01-14 |
2010-11-30 |
Ablynx Nv |
Postopki in testi za razlikovanje med različnimioblikami bolezni in motenj ki so označene s trombocitopenijo in ali s spontano interakcijo med von Willebrandovim faktorjem vWF in krvnimi ploščicami
|
|
AU2006249144B2
(en)
|
2005-05-18 |
2011-11-17 |
Ablynx Nv |
Improved NanobodiesTM against Tumor Necrosis Factor-alpha
|
|
LT2444424T
(lt)
|
2005-05-20 |
2018-10-25 |
Ablynx N.V. |
Pagerintos tm nanodalelės, skirtos agregacijos sąlygotų sutrikimų gydymui
|
|
WO2007082899A1
(en)
|
2006-01-17 |
2007-07-26 |
Vib Vzw |
Inhibitors of prolyl-hydroxylase 1 for the treatment of skeletal muscle degeneration
|
|
TWI417301B
(zh)
|
2006-02-21 |
2013-12-01 |
Wyeth Corp |
對抗人類介白素-２２（ｉｌ-２２）之抗體及其用途
|
|
TW200744634A
(en)
*
|
2006-02-21 |
2007-12-16 |
Wyeth Corp |
Methods of using antibodies against human IL-22
|
|
LT3028716T
(lt)
|
2006-10-10 |
2020-12-10 |
Regenesance B.V. |
Komplemento slopinimas nervų regeneracijos pagerinimui
|
|
GB0621513D0
(en)
|
2006-10-30 |
2006-12-06 |
Domantis Ltd |
Novel polypeptides and uses thereof
|
|
WO2008055924A1
(en)
|
2006-11-07 |
2008-05-15 |
Vib Vzw |
Diagnosis and treatment of t-cell acute lymphoblastic leukemia
|
|
AU2007325838B2
(en)
|
2006-11-22 |
2013-09-19 |
Bristol-Myers Squibb Company |
Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR
|
|
US9156914B2
(en)
|
2006-12-19 |
2015-10-13 |
Ablynx N.V. |
Amino acid sequences directed against a metalloproteinase from the ADAM family and polypeptides comprising the same for the treatment of ADAM-related diseases and disorders
|
|
AU2007336242B2
(en)
|
2006-12-19 |
2012-08-30 |
Ablynx N.V. |
Amino acid sequences directed against GPCRs and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders
|
|
WO2008118013A2
(en)
|
2007-03-23 |
2008-10-02 |
To-Bbb Holding B.V. |
Targeted intracellular delivery of antiviral agents
|
|
AU2008270274B2
(en)
|
2007-07-03 |
2012-06-28 |
Ablynx N.V. |
Providing improved immunoglobulin sequences by mutating CDR and/or FR positions
|
|
MX2010004761A
(es)
|
2007-11-02 |
2010-05-19 |
Novartis Ag |
Moleculas y metodos para modular la proteina relacionada con el receptor de lipoproteina de baja densidad 6 (lrp6).
|
|
CA2706425A1
(en)
|
2007-11-27 |
2009-06-04 |
Ablynx N.V. |
Method for obtaining polypeptide constructs comprising two or more single domain antibodies
|
|
GB0800277D0
(en)
|
2008-01-08 |
2008-02-13 |
Imagination Tech Ltd |
Video motion compensation
|
|
US20110091462A1
(en)
|
2008-03-05 |
2011-04-21 |
Ablynx N.V. |
Novel antigen binding dimer-complexes, methods of making and uses thereof
|
|
KR101568042B1
(ko)
|
2008-03-31 |
2015-11-10 |
가부시끼가이샤 히다치 세이사꾸쇼 |
감쇠력 조정식 완충기
|
|
GB0809069D0
(en)
|
2008-05-19 |
2008-06-25 |
Univ Leuven Kath |
Gene signatures
|
|
US8557965B2
(en)
|
2008-04-07 |
2013-10-15 |
Ablynx N.V. |
Single variable domains against notch pathway members
|
|
CA2721202A1
(en)
|
2008-04-17 |
2009-10-22 |
Hilde Adi Pierrette Revets |
Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same
|
|
US9212226B2
(en)
|
2008-05-16 |
2015-12-15 |
Ablynx N.V. |
Amino acid sequences directed against CXCR4 and other GPCRs and compounds comprising the same
|
|
AR071874A1
(es)
|
2008-05-22 |
2010-07-21 |
Bristol Myers Squibb Co |
Proteinas de dominio de armazon basadas en fibronectina multivalentes
|
|
WO2010039533A2
(en)
|
2008-09-23 |
2010-04-08 |
Wyeth |
Methods for predicting production of activating signals by cross-linked binding proteins
|
|
GB0900425D0
(en)
|
2009-01-12 |
2009-02-11 |
Ucb Pharma Sa |
Biological products
|
|
US9085795B2
(en)
|
2009-02-04 |
2015-07-21 |
Molecular Innovations, Inc. |
Methods for screening candidate agents for modulating prorenin and renin, assays for detecting prorenin and antibodies
|
|
EP2403873A1
(de)
|
2009-03-05 |
2012-01-11 |
Ablynx N.V. |
Neue antigenbindende dimerkomplexe, verfahren zur herstellung/vermeidung und anwendungen davon
|
|
CA2759370C
(en)
|
2009-04-30 |
2020-02-11 |
Peter Schotte |
Method for the production of domain antibodies
|
|
CA2766409C
(en)
|
2009-07-03 |
2023-04-25 |
Avipep Pty Ltd |
Immuno-conjugates and methods for producing them
|
|
DK3241435T3
(da)
|
2009-07-08 |
2021-08-23 |
Kymab Ltd |
Dyremodeller og terapeutiske molekyler
|
|
ES2804450T3
(es)
|
2009-07-10 |
2021-02-08 |
Ablynx Nv |
Método para la producción de dominios variables
|
|
EP2459053A2
(de)
|
2009-07-28 |
2012-06-06 |
F. Hoffmann-La Roche AG |
Nicht invasives optisches in-vivo-bildgebungsverfahren
|
|
WO2011027132A1
(en)
|
2009-09-03 |
2011-03-10 |
Cancer Research Technology Limited |
Clec14a inhibitors
|
|
EP2473528B1
(de)
|
2009-09-03 |
2014-12-03 |
Ablynx N.V. |
Stabile formulierungen aus polypeptiden und verwendungen davon
|
|
GB0922435D0
(en)
|
2009-12-22 |
2010-02-03 |
Ucb Pharma Sa |
Method
|
|
GB0922434D0
(en)
|
2009-12-22 |
2010-02-03 |
Ucb Pharma Sa |
antibodies and fragments thereof
|
|
CN102781963B
(zh)
|
2009-10-27 |
2018-02-16 |
Ucb医药有限公司 |
功能修饰性NAv1.7抗体
|
|
US9234037B2
(en)
|
2009-10-27 |
2016-01-12 |
Ucb Biopharma Sprl |
Method to generate antibodies to ion channels
|
|
CA2784610C
(en)
|
2009-12-23 |
2020-07-14 |
Avipep Pty Ltd |
Immuno-conjugates and methods for producing them
|
|
WO2011083140A1
(en)
|
2010-01-08 |
2011-07-14 |
Ablynx Nv |
Immunoglobulin single variable domain directed against human cxcr4
|
|
EP2531523A1
(de)
|
2010-02-05 |
2012-12-12 |
Ablynx N.V. |
An serumalbumin bindende peptide und verbindungen, konstrukte und polypeptide damit
|
|
SI2533761T1
(sl)
|
2010-02-11 |
2019-08-30 |
Ablynx N.V. |
Postopki in sestavki za pripravo aerosolov
|
|
AU2011231558B2
(en)
|
2010-03-26 |
2016-08-11 |
Westfaelische Wilhelms-Universitaet Muenster |
Substitute therapy for glucocorticoids
|
|
US9556273B2
(en)
|
2010-03-29 |
2017-01-31 |
Vib Vzw |
Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages
|
|
US9101674B2
(en)
|
2010-03-29 |
2015-08-11 |
Vib Vzw |
Targeting and in vivo imaging of tumor-associated macrophages
|
|
GB201105584D0
(en)
|
2011-04-01 |
2011-05-18 |
Imp Innovations Ltd |
Cancer methods
|
|
RU2012148816A
(ru)
|
2010-05-07 |
2014-06-20 |
Ф. Хоффманн-Ля Рош Аг |
Метод диагностики для определения клеток ex vivo
|
|
WO2011161263A1
(en)
|
2010-06-25 |
2011-12-29 |
Ablynx Nv |
Pharmaceutical compositions for cutaneous administration
|
|
US20130149297A1
(en)
|
2010-07-02 |
2013-06-13 |
Vib Vzw |
Role of fragile x mental retardation gene and protein in cancer metastasis
|
|
GB201012845D0
(en)
|
2010-07-30 |
2010-09-15 |
Vib Vzw |
Inhibition of dicer function for treatment of cancer
|
|
US20120244141A1
(en)
|
2010-09-28 |
2012-09-27 |
Boehringer Ingelheim International Gmbh |
Stratification of cancer patients for susceptibility to therapy with PTK2 inhibitors
|
|
EP2632946B1
(de)
|
2010-10-29 |
2017-12-06 |
Ablynx N.V. |
Verfahren zur herstellung von variablen immunglobulin-einzeldomänen
|
|
GB201018602D0
(en)
|
2010-11-04 |
2010-12-22 |
Vib Vzw |
MMP8 inactivating antigen binding proteins
|
|
JP6100704B2
(ja)
|
2011-03-07 |
2017-03-22 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
治療用抗体についてのインビボ試験の手段および方法
|
|
WO2012120004A1
(en)
|
2011-03-07 |
2012-09-13 |
F. Hoffmann-La Roche Ag |
In vivo selection of therapeutically active antibodies
|
|
WO2012122590A1
(en)
|
2011-03-14 |
2012-09-20 |
Cellmid Limited |
Antibody recognizing n-domain of midkine
|
|
WO2012130872A1
(en)
|
2011-03-28 |
2012-10-04 |
Ablynx Nv |
Method for producing solid formulations comprising immunoglobulin single variable domains
|
|
EP3590950A1
(de)
|
2011-05-09 |
2020-01-08 |
Ablynx NV |
Verfahren zur herstellung von einzelvariablen immunglobulindomänen
|
|
US9505840B2
(en)
|
2011-05-27 |
2016-11-29 |
Ablynx N.V. |
Inhibition of bone resorption with RANKL binding peptides
|
|
US9580480B2
(en)
|
2011-05-31 |
2017-02-28 |
Massachusetts Institute Of Technology |
Cell-directed synthesis of multifunctional nanopatterns and nanomaterials
|
|
RU2605595C2
(ru)
|
2011-06-13 |
2016-12-20 |
СиЭсЭл Лимитид |
Антитела против g-csfr и их применение
|
|
AU2012273928A1
(en)
|
2011-06-23 |
2014-02-06 |
Ablynx Nv |
Immunoglobulin single variable domains directed against IgE
|
|
GB201112056D0
(en)
|
2011-07-14 |
2011-08-31 |
Univ Leuven Kath |
Antibodies
|
|
GB201115529D0
(en)
|
2011-09-08 |
2011-10-26 |
Imp Innovations Ltd |
Antibodies, uses and methods
|
|
AU2012311286B2
(en)
|
2011-09-19 |
2018-07-26 |
Kymab Limited |
Antibodies, variable domains and chains tailored for human use
|
|
WO2013041722A1
(en)
|
2011-09-23 |
2013-03-28 |
Ablynx Nv |
Prolonged inhibition of interleukin-6 mediated signaling
|
|
JP2015504413A
(ja)
|
2011-10-28 |
2015-02-12 |
パトリス リミテッド |
Ｐａｔ−ｌｍ１エピトープおよびそれを使用するための方法
|
|
US9253965B2
(en)
|
2012-03-28 |
2016-02-09 |
Kymab Limited |
Animal models and therapeutic molecules
|
|
WO2013079973A1
(en)
|
2011-12-02 |
2013-06-06 |
Di Cara Danielle Marie |
Antibodies against hgf - receptor and uses
|
|
US20150301068A1
(en)
|
2012-01-30 |
2015-10-22 |
Vib Vzw |
Means and method for diagnosis and treatment of alzheimer's disease
|
|
WO2013121042A1
(en)
|
2012-02-16 |
2013-08-22 |
Vib Vzw |
PP2A SUBUNITS IN DNA REPAIR, THE PP2A B55α SUBUNIT AS NOVEL PHD2 INTERACTING PROTEIN, AND IMPLICATIONS FOR CANCER
|
|
US10251377B2
(en)
|
2012-03-28 |
2019-04-09 |
Kymab Limited |
Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies
|
|
GB2502127A
(en)
|
2012-05-17 |
2013-11-20 |
Kymab Ltd |
Multivalent antibodies and in vivo methods for their production
|
|
ES2715279T3
(es)
|
2012-05-24 |
2019-06-03 |
Vib Vzw |
Dominios variables individuales inmunoglobulínicos anti-receptor de manosa de macrófagos para elegir como diana y obtener imágenes in vivo de macrófagos asociados a tumores
|
|
US11339208B1
(en)
|
2012-05-31 |
2022-05-24 |
United States Of America As Represented By The Secretary Of The Air Force |
Camelidae single-domain antibodies against Yersinia pestis and methods of use
|
|
US10048253B2
(en)
|
2012-06-28 |
2018-08-14 |
Ucb Biopharma Sprl |
Method for identifying compounds of therapeutic interest
|
|
WO2014087010A1
(en)
|
2012-12-07 |
2014-06-12 |
Ablynx N.V. |
IMPROVED POLYPEPTIDES DIRECTED AGAINST IgE
|
|
DK2951201T3
(en)
|
2013-01-30 |
2018-01-08 |
Vib Vzw |
Novel chimeric polypeptides for screening and drug detection purposes
|
|
WO2014122183A1
(en)
|
2013-02-05 |
2014-08-14 |
Vib Vzw |
Muscarinic acetylcholine receptor binding agents and uses thereof
|
|
PT2953971T
(pt)
|
2013-02-07 |
2023-05-02 |
Csl Ltd |
Proteínas de ligação à il-11r e suas utilizações
|
|
US9617339B2
(en)
|
2013-03-15 |
2017-04-11 |
Vib Vzw |
Method of imaging a cardiovascular disease with an anti-macrophage mannose receptor immunoglobulin single variable domain
|
|
WO2014144292A2
(en)
|
2013-03-15 |
2014-09-18 |
Sanofi Pasteur Biologics , Llc |
Antibodies against clostridium difficile toxins and methods of using the same
|
|
US9788534B2
(en)
|
2013-03-18 |
2017-10-17 |
Kymab Limited |
Animal models and therapeutic molecules
|
|
CN114732017A
(zh)
|
2013-04-29 |
2022-07-12 |
阿格罗塞文公司 |
包含结合至鞘脂的抗体的农用化学组合物
|
|
US11707056B2
(en)
|
2013-05-02 |
2023-07-25 |
Kymab Limited |
Animals, repertoires and methods
|
|
US9783593B2
(en)
|
2013-05-02 |
2017-10-10 |
Kymab Limited |
Antibodies, variable domains and chains tailored for human use
|
|
NL1040254C2
(en)
|
2013-05-17 |
2014-11-24 |
Ablynx Nv |
Stable formulations of immunoglobulin single variable domains and uses thereof.
|
|
WO2015049517A2
(en)
|
2013-10-01 |
2015-04-09 |
Kymab Limited |
Animal models and therapeutic molecules
|
|
TR201900665T4
(tr)
|
2013-11-28 |
2019-02-21 |
B Creative Sweden Ab |
Diyabetik nefropatinin tedavi yöntemi.
|
|
EP2883883A1
(de)
|
2013-12-16 |
2015-06-17 |
Cardio3 Biosciences S.A. |
Therapeutische Ziele und Mittel zur Behandlung von ischämiebedingten Reperfusionsschäden
|
|
US9067998B1
(en)
|
2014-07-15 |
2015-06-30 |
Kymab Limited |
Targeting PD-1 variants for treatment of cancer
|
|
US9045545B1
(en)
|
2014-07-15 |
2015-06-02 |
Kymab Limited |
Precision medicine by targeting PD-L1 variants for treatment of cancer
|
|
US8986694B1
(en)
|
2014-07-15 |
2015-03-24 |
Kymab Limited |
Targeting human nav1.7 variants for treatment of pain
|
|
US9914769B2
(en)
|
2014-07-15 |
2018-03-13 |
Kymab Limited |
Precision medicine for cholesterol treatment
|
|
US8992927B1
(en)
|
2014-07-15 |
2015-03-31 |
Kymab Limited |
Targeting human NAV1.7 variants for treatment of pain
|
|
CN105979965B
(zh)
|
2013-12-18 |
2021-07-09 |
杰特有限公司 |
治疗伤口的方法
|
|
WO2015121092A1
(en)
|
2014-01-30 |
2015-08-20 |
Vib Vzw |
Opioid receptor binding agents and uses thereof
|
|
GB201403775D0
(en)
|
2014-03-04 |
2014-04-16 |
Kymab Ltd |
Antibodies, uses & methods
|
|
NL2013661B1
(en)
|
2014-10-21 |
2016-10-05 |
Ablynx Nv |
KV1.3 Binding immunoglobulins.
|
|
US9139648B1
(en)
|
2014-07-15 |
2015-09-22 |
Kymab Limited |
Precision medicine by targeting human NAV1.9 variants for treatment of pain
|
|
PT3194976T
(pt)
|
2014-07-22 |
2020-07-03 |
Univ Brussel Vrije |
Métodos para selecionar agentes que estabilizam complexos proteicos
|
|
WO2016016329A1
(en)
|
2014-07-29 |
2016-02-04 |
Vrije Universiteit Brussel |
Radio-labelled antibody fragments for use in the prognosis, diagnosis of cancer as well as for the prediction of cancer therapy response
|
|
JP6289733B2
(ja)
|
2014-07-29 |
2018-03-07 |
フレイエ ユニヴェルシテイト ブリュッセルＶｒｉｊｅ Ｕｎｉｖｅｒｓｉｔｅｉｔ Ｂｒｕｓｓｅｌ |
癌の予防及び／又は治療に用いるための放射標識抗体断片
|
|
WO2016061632A1
(en)
|
2014-10-23 |
2016-04-28 |
La Trobe University |
Fn14-binding proteins and uses thereof
|
|
US10858666B2
(en)
|
2014-11-05 |
2020-12-08 |
Biotalys |
Transgenic plants expressing a variable domain of a heavy chain antibody (VHH) that binds to a sphingolipid of a fungus
|
|
AU2015366284B2
(en)
|
2014-12-19 |
2021-07-22 |
Ablynx N.V. |
Cysteine linked nanobody dimers
|
|
EP3233120A4
(de)
|
2014-12-19 |
2018-05-30 |
Monash University |
Il-21-antikörper
|
|
GB201501004D0
(en)
|
2015-01-21 |
2015-03-04 |
Cancer Rec Tech Ltd |
Inhibitors
|
|
US9139653B1
(en)
|
2015-04-30 |
2015-09-22 |
Kymab Limited |
Anti-human OX40L antibodies and methods of treatment
|
|
KR20250174696A
(ko)
|
2015-07-17 |
2025-12-12 |
브리제 유니버시타이트 브루셀 |
암 치료에 사용하기 위한 방사성 표지된 항체 단편
|
|
CN105384825B
(zh)
|
2015-08-11 |
2018-06-01 |
南京传奇生物科技有限公司 |
一种基于单域抗体的双特异性嵌合抗原受体及其应用
|
|
GB201518675D0
(en)
|
2015-10-21 |
2015-12-02 |
Cellcap Technologies Ltd |
Detection of structural forms of proteins
|
|
CA3006398A1
(en)
|
2015-11-27 |
2017-06-01 |
Ablynx Nv |
Polypeptides inhibiting cd40l
|
|
AU2016361462B2
(en)
|
2015-11-27 |
2023-09-21 |
Csl Limited |
CD131 binding proteins and uses thereof
|
|
WO2017097889A1
(en)
|
2015-12-10 |
2017-06-15 |
Katholieke Universiteit Leuven |
Anti adamts13 antibodies and their use for treatment or prevention of haemorrhagic disorders due to ventricular assist device
|
|
US11243214B2
(en)
|
2016-04-22 |
2022-02-08 |
Université Libre de Bruxelles |
Biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells
|
|
WO2017182605A1
(en)
|
2016-04-22 |
2017-10-26 |
Université Libre de Bruxelles |
A new biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells
|
|
WO2017191108A1
(en)
|
2016-05-02 |
2017-11-09 |
Ablynx Nv |
Treatment of rsv infection
|
|
KR102379464B1
(ko)
|
2016-06-20 |
2022-03-29 |
키맵 리미티드 |
항-pd-l1 항체
|
|
WO2018007442A1
(en)
|
2016-07-06 |
2018-01-11 |
Ablynx N.V. |
Treatment of il-6r related diseases
|
|
WO2018014260A1
(en)
|
2016-07-20 |
2018-01-25 |
Nanjing Legend Biotech Co., Ltd. |
Multispecific antigen binding proteins and methods of use thereof
|
|
WO2018029182A1
(en)
|
2016-08-08 |
2018-02-15 |
Ablynx N.V. |
Il-6r single variable domain antibodies for treatment of il-6r related diseases
|
|
PL3896091T3
(pl)
|
2016-08-10 |
2024-04-29 |
Legend Biotech Ireland Limited |
Chimeryczne receptory antygenowe nakierowane na bcma i sposoby ich zastosowania
|
|
US11098113B2
(en)
|
2016-09-15 |
2021-08-24 |
Vib Vzw |
Immunoglobulin single variable domains directed against macrophage migration inhibitory factor
|
|
CA3034105A1
(en)
|
2016-09-23 |
2018-03-29 |
Csl Limited |
Coagulation factor binding proteins and uses thereof
|
|
WO2018068201A1
(en)
|
2016-10-11 |
2018-04-19 |
Nanjing Legend Biotech Co., Ltd. |
Single-domain antibodies and variants thereof against ctla-4
|
|
WO2018083248A1
(en)
|
2016-11-03 |
2018-05-11 |
Kymab Limited |
Antibodies, combinations comprising antibodies, biomarkers, uses & methods
|
|
US11840569B2
(en)
|
2016-11-16 |
2023-12-12 |
Ablynx N.V. |
T cell recruiting polypeptides capable of binding CD123 and TCR alpha/beta
|
|
WO2018099968A1
(en)
|
2016-11-29 |
2018-06-07 |
Ablynx N.V. |
Treatment of infection by respiratory syncytial virus (rsv)
|
|
JP7186401B2
(ja)
|
2017-02-28 |
2022-12-09 |
フエー・イー・ベー・フエー・ゼツト・ウエー |
タンパク質の経口送達のための手段及び方法
|
|
CA3058290A1
(en)
|
2017-04-18 |
2018-10-25 |
Universite Libre De Bruxelles |
Biomarkers and targets for proliferative diseases
|
|
KR20200005635A
(ko)
|
2017-05-11 |
2020-01-15 |
브이아이비 브이지더블유 |
가변 면역글로불린 도메인의 글리코실화
|
|
IL270951B2
(en)
|
2017-06-02 |
2025-05-01 |
Merck Patent Gmbh |
ADAMTS5, MMP13 and aggrecan-binding polypeptides
|
|
CN118085076A
(zh)
|
2017-06-02 |
2024-05-28 |
埃博灵克斯股份有限公司 |
结合聚集蛋白聚糖的免疫球蛋白
|
|
US11261260B2
(en)
|
2017-06-02 |
2022-03-01 |
Merck Patent Gmbh |
ADAMTS binding immunoglobulins
|
|
CN110997001A
(zh)
|
2017-06-02 |
2020-04-10 |
默克专利股份有限公司 |
Mmp13结合免疫球蛋白
|
|
GB201709379D0
(en)
|
2017-06-13 |
2017-07-26 |
Univ Leuven Kath |
Humanised ADAMTS13 binding antibodies
|
|
WO2019000223A1
(en)
|
2017-06-27 |
2019-01-03 |
Nanjing Legend Biotech Co., Ltd. |
ENABLERS OF IMMUNE EFFECTOR CELLS OF CHIMERIC ANTIBODIES AND METHODS OF USE THEREOF
|
|
GB201710984D0
(en)
|
2017-07-07 |
2017-08-23 |
Kymab Ltd |
Cells, vertebrates, populations & methods
|
|
IL307197B2
(en)
|
2017-07-11 |
2026-03-01 |
Alexion Pharma Inc |
Polypeptides that bind complement component c5 or serum albumin and fusion proteins thereof
|
|
CA3070253A1
(en)
|
2017-07-19 |
2019-01-24 |
Vib Vzw |
Serum albumin binding agents
|
|
WO2019016784A1
(en)
|
2017-07-21 |
2019-01-24 |
Universidade De Coimbra |
ANTI-NUCLEOLIN ANTIBODIES
|
|
KR102755742B1
(ko)
|
2017-09-11 |
2025-01-15 |
모나쉬 유니버시티 |
인간 트롬빈 수용체 par4 결합 단백질
|
|
WO2019067015A1
(en)
|
2017-09-29 |
2019-04-04 |
City Of Hope |
RECEPTORS OF CHIMERIC ANTIGENS AND BISPECIFIC ANTIBODIES FOR THE TREATMENT OF COAT CELL LYMPHOMA
|
|
KR102715492B1
(ko)
|
2017-10-18 |
2024-10-11 |
씨에스엘 리미티드 |
인간 혈청 알부민 변이체 및 이의 용도
|
|
EP4635987A3
(de)
|
2017-10-31 |
2026-01-14 |
Vib Vzw |
Neue antigenbindende chimäre proteine sowie verfahren und verwendungen davon
|
|
US10017560B1
(en)
|
2017-11-16 |
2018-07-10 |
King Saud University |
Nanobody against begomoviruses
|
|
US20210179721A1
(en)
|
2017-11-29 |
2021-06-17 |
Csl Limited |
Method of treating or preventing ischemia-reperfusion injury
|
|
US11639496B2
(en)
|
2017-12-05 |
2023-05-02 |
Celyad S.A. |
Reducing fratricide of immune cells expressing NKG2D-based receptors
|
|
WO2019110693A1
(en)
|
2017-12-05 |
2019-06-13 |
Celyad S.A. |
Compositions and methods for improving persistence of cells for adoptive transfer
|
|
SG11202004158QA
(en)
|
2017-12-28 |
2020-06-29 |
Nanjing Legend Biotech Co Ltd |
Single-domain antibodies and variants thereof against tigit
|
|
CA3087331A1
(en)
|
2017-12-29 |
2019-07-04 |
City Of Hope |
Meditope-enabled t cells
|
|
CA3084518A1
(en)
|
2018-01-15 |
2019-07-18 |
Nanjing Legend Biotech Co., Ltd. |
Single-domain antibodies and variants thereof against pd-1
|
|
WO2019155041A1
(en)
|
2018-02-12 |
2019-08-15 |
Vib Vzw |
Gβγ COMPLEX ANTIBODIES AND USES THEREOF
|
|
WO2019166622A1
(en)
|
2018-03-01 |
2019-09-06 |
Vrije Universiteit Brussel |
Human pd-l1-binding immunoglobulins
|
|
US12281160B2
(en)
|
2018-03-23 |
2025-04-22 |
Csl Limited |
Method of treating asthma
|
|
JP7390729B2
(ja)
|
2018-03-23 |
2023-12-04 |
ユニヴェルシテ リブル ドゥ ブリュッセル |
Ｗｎｔシグナル伝達アゴニスト分子
|
|
JP2021519093A
(ja)
|
2018-03-27 |
2021-08-10 |
ユーエムシー ユトレヒト ホールディング ビー．ブイ． |
微小血管血栓症の処置のための標的化血栓溶解
|
|
AU2019241350B2
(en)
|
2018-03-30 |
2025-10-02 |
Nanjing Legend Biotech Co., Ltd. |
Single-domain antibodies against LAG-3 and uses thereof
|
|
WO2020041758A1
(en)
|
2018-08-24 |
2020-02-27 |
City Of Hope |
Masked cytokine conjugates
|
|
GB201814451D0
(en)
|
2018-09-05 |
2018-10-17 |
Valerie Nicholas Carl Kristoffer |
Methods
|
|
CA3314168A1
(en)
|
2019-04-29 |
2026-08-05 |
Confo Therapeutics N.V. |
Screening methods and assays for use with transmembrane proteins, in particular with gpcrs
|
|
US20220289837A1
(en)
|
2019-04-30 |
2022-09-15 |
Vib Vzw |
Cystic Fibrosis Transmembrane Conductance Regulator Stabilizing Agents
|
|
EP3976067A1
(de)
|
2019-05-28 |
2022-04-06 |
Vib Vzw |
Cd8+-t-zellen ohne plexine und ihre anwendung zur krebsbehandlung
|
|
WO2020239945A1
(en)
|
2019-05-28 |
2020-12-03 |
Vib Vzw |
Cancer treatment by targeting plexins in the immune compartment
|
|
GB2584441A
(en)
|
2019-06-03 |
2020-12-09 |
Fenomark Diagnostics Ab |
Medical uses, methods and uses
|
|
JP7171737B2
(ja)
*
|
2019-07-23 |
2022-11-15 |
源道隆（蘇州）医学科技有限公司 |
Ｓｆｔｓｖに結合可能なナノ抗体及びその使用
|
|
CN114502583A
(zh)
|
2019-08-12 |
2022-05-13 |
杰特创新股份有限公司 |
补体c2结合蛋白及其用途
|
|
US20220380456A1
(en)
|
2019-10-21 |
2022-12-01 |
Vib Vzw |
Nanodisc-specific antigen-binding chimeric proteins
|
|
CA3158174A1
(en)
|
2019-10-28 |
2021-05-06 |
Monash University |
Antibodies for binding plasmin
|
|
CA3160506A1
(en)
|
2019-11-11 |
2021-05-20 |
Ibi-Ag Innovative Bio Insecticides Ltd. |
Insect control nanobodies and uses thereof
|
|
CA3158991A1
(en)
|
2019-11-27 |
2021-06-03 |
Vib Vzw |
Positive allosteric modulators of the calcium-sensing receptor
|
|
GB201918279D0
(en)
|
2019-12-12 |
2020-01-29 |
Vib Vzw |
Glycosylated single chain immunoglobulin domains
|
|
WO2021123360A1
(en)
|
2019-12-20 |
2021-06-24 |
Vib Vzw |
Nanobody exchange chromatography
|
|
JP7807372B2
(ja)
|
2019-12-20 |
2026-01-27 |
ハドソン インスティチュート オブ メディカル リサーチ |
Ｃｘｃｌ１０結合タンパク質及びその使用
|
|
WO2021140205A1
(en)
|
2020-01-10 |
2021-07-15 |
Confo Therapeutics N.V. |
Methods for generating antibodies and antibody fragments and libraries comprising same
|
|
WO2021156490A2
(en)
|
2020-02-06 |
2021-08-12 |
Vib Vzw |
Corona virus binders
|
|
CA3173090A1
(en)
|
2020-02-25 |
2021-09-02 |
Vib Vzw |
Leucine-rich repeat kinase 2 allosteric modulators
|
|
AU2021250446A1
(en)
|
2020-03-31 |
2022-11-17 |
Biotalys NV |
Anti-fungal polypeptides
|
|
EP4144758A4
(de)
|
2020-04-22 |
2024-05-15 |
Mabwell (Shanghai) Bioscience Co., Ltd. |
Gegen den humanen liganden 1 für programmierten zelltod (pd-l1) gerichteter einzelvariabler domänenantikörper und derivat davon
|
|
WO2021229104A1
(en)
|
2020-05-15 |
2021-11-18 |
Université de Liège |
Anti-cd38 single-domain antibodies in disease monitoring and treatment
|
|
AU2021274836A1
(en)
|
2020-05-19 |
2023-01-05 |
Aarhus Universitet |
Lysm receptor motifs
|
|
CN115768475A
(zh)
|
2020-06-04 |
2023-03-07 |
Csl创新私人有限公司 |
治疗或预防急性呼吸窘迫综合征的方法
|
|
WO2022003156A1
(en)
|
2020-07-02 |
2022-01-06 |
Oncurious Nv |
Ccr8 non-blocking binders
|
|
JP7846667B2
(ja)
|
2020-07-16 |
2026-04-15 |
レジェンド バイオテック アイルランド リミテッド |
Ｃｄ２０結合分子及びその使用
|
|
CA3186065A1
(en)
|
2020-07-16 |
2022-01-20 |
Xiaohu FAN |
Cd19 binding molecules and uses thereof
|
|
US20240279595A1
(en)
|
2020-07-31 |
2024-08-22 |
Biotalys NV |
Expression host
|
|
WO2022035998A1
(en)
|
2020-08-11 |
2022-02-17 |
City Of Hope |
Compositions and uses of sars-cov-2 targeted chimeric antigen receptor modified nk cells
|
|
WO2022063947A1
(en)
|
2020-09-24 |
2022-03-31 |
Vib Vzw |
Combination of p2y6 inhibitors and immune checkpoint inhibitors
|
|
WO2022063957A1
(en)
|
2020-09-24 |
2022-03-31 |
Vib Vzw |
Biomarker for anti-tumor therapy
|
|
WO2022063984A1
(en)
|
2020-09-25 |
2022-03-31 |
Ablynx Nv |
Polypeptides comprising immunoglobulin single variable domains targeting il-13 and ox40l
|
|
WO2022117569A1
(en)
|
2020-12-02 |
2022-06-09 |
Oncurious Nv |
A ccr8 antagonist antibody in combination with a lymphotoxin beta receptor agonist antibody in therapy against cancer
|
|
JP2024508207A
(ja)
|
2020-12-02 |
2024-02-26 |
ブイアイビー ブイゼットダブリュ |
がんに対する組み合わせ治療におけるｌｔｂｒアゴニスト
|
|
WO2022129572A1
(en)
|
2020-12-18 |
2022-06-23 |
Ablynx Nv |
Polypeptides comprising immunoglobulin single variable domains targeting il-6 and tnf-alpha
|
|
GB202020502D0
(en)
|
2020-12-23 |
2021-02-03 |
Vib Vzw |
Antibody composistion for treatment of corona virus infection
|
|
WO2022136649A1
(en)
|
2020-12-24 |
2022-06-30 |
Oncurious Nv |
Non-blocking human ccr8 binders
|
|
EP4267617A1
(de)
|
2020-12-24 |
2023-11-01 |
Vib Vzw |
Menschliche ccr8-bindemittel
|
|
CA3206125A1
(en)
|
2020-12-24 |
2022-06-30 |
Vib Vzw |
Murine cross-reactive human ccr8 binders
|
|
GB2603166A
(en)
|
2021-01-29 |
2022-08-03 |
Thelper As |
Therapeutic and Diagnostic Agents and Uses Thereof
|
|
CN117794566A
(zh)
|
2021-02-05 |
2024-03-29 |
Vib研究所 |
沙贝病毒结合剂
|
|
EP4288095A1
(de)
|
2021-02-05 |
2023-12-13 |
Vib Vzw |
Sarbecovirus-bindemittel
|
|
CN117241804A
(zh)
|
2021-02-17 |
2023-12-15 |
非营利性组织佛兰芒综合大学生物技术研究所 |
在癌症治疗中slc4a4的抑制
|
|
US20250263490A1
(en)
|
2021-02-19 |
2025-08-21 |
Vib Vzw |
Cation-Independent Mannose-6-Phosphate Receptor Binders
|
|
WO2022199804A1
(en)
|
2021-03-24 |
2022-09-29 |
Vib Vzw |
Nek6 inhibition to treat als and ftd
|
|
WO2022242892A1
(en)
|
2021-05-17 |
2022-11-24 |
Université de Liège |
Anti-cd38 single-domain antibodies in disease monitoring and treatment
|
|
CA3225194A1
(en)
|
2021-06-23 |
2022-12-29 |
Vib Vzw |
Means and methods for selection of specific binders
|
|
JP2024524378A
(ja)
|
2021-06-29 |
2024-07-05 |
山▲東▼先声生物制▲薬▼有限公司 |
Ｃｄ１６抗体及びその応用
|
|
US20240343803A1
(en)
|
2021-07-30 |
2024-10-17 |
Shandong Simcere Biopharmaceutical Co., Ltd. |
Anti-Pvrig/Anti-Tigit Bispecific Antibodies And Applications Thereof
|
|
EP4377352A2
(de)
|
2021-07-30 |
2024-06-05 |
Vib Vzw |
Kationunabhängige mannose-6-phosphat-rezeptorbindemittel für gezielten proteinabbau
|
|
MX2024001877A
(es)
|
2021-08-10 |
2024-02-28 |
Kymab Ltd |
Tratamiento de dermatitis atopica.
|
|
WO2023023220A1
(en)
|
2021-08-20 |
2023-02-23 |
Alexion Pharmaceuticals, Inc. |
Methods for treating sickle cell disease or beta thalassemia using a complement alternative pathway inhibitor
|
|
US20240343787A1
(en)
|
2021-08-20 |
2024-10-17 |
Alexion Pharmaceuticals, Inc. |
Methods for treating sickle cell disease or beta thalassemia using complement alternative pathway inhibitors
|
|
WO2023057601A1
(en)
|
2021-10-06 |
2023-04-13 |
Biotalys NV |
Anti-fungal polypeptides
|
|
WO2023079137A1
(en)
|
2021-11-05 |
2023-05-11 |
Katholieke Universiteit Leuven |
Neutralizing anti-sars-cov-2 human antibodies
|
|
EP4177266A1
(de)
|
2021-11-05 |
2023-05-10 |
Katholieke Universiteit Leuven |
Neutralisierende humane anti-sars-cov-2-antikörper
|
|
EP4428156A4
(de)
|
2021-12-03 |
2026-03-04 |
Shandong Simcere Biopharmaceutical Co., Ltd. |
Anti-bcma-nanokörper und verwendung davon
|
|
TW202342508A
(zh)
|
2021-12-17 |
2023-11-01 |
比利時商艾伯霖克斯公司 |
包含靶向ＴＣＲαβ、ＣＤ３３和ＣＤ１２３的免疫球蛋白單可變結構域的多肽
|
|
WO2023125888A1
(zh)
|
2021-12-31 |
2023-07-06 |
山东先声生物制药有限公司 |
一种gprc5d抗体及其应用
|
|
EP4463479A1
(de)
|
2022-01-12 |
2024-11-20 |
Vib Vzw |
Humane ntcp-bindemittel für therapeutische verwendung und leberspezifische gezielte abgabe
|
|
GB202201137D0
(en)
|
2022-01-28 |
2022-03-16 |
Thelper As |
Therapeutic and diagnostic agents and uses thereof
|
|
WO2023148291A1
(en)
|
2022-02-02 |
2023-08-10 |
Biotalys NV |
Methods for genome editing
|
|
EP4476250A1
(de)
|
2022-02-07 |
2024-12-18 |
Vib Vzw |
Gentechnisch veränderte stabilisierung aglycosylierter fc-regionen
|
|
US20250235534A1
(en)
|
2022-04-13 |
2025-07-24 |
Vib Vzw |
An LTBR Agonist In Combination Therapy Against Cancer
|
|
US20250289904A1
(en)
|
2022-05-02 |
2025-09-18 |
Umc Utrecht Holding B.V. |
Single domain antibodies for the detection of plasmin-cleaved vwf
|
|
US20250313611A1
(en)
|
2022-05-18 |
2025-10-09 |
Vib Vzw |
Sarbecovirus spike s2 subunit binders
|
|
WO2023236889A1
(zh)
|
2022-06-06 |
2023-12-14 |
山东先声生物制药有限公司 |
靶向bcma、gprc5d和t细胞的多特异性抗体及其应用
|
|
US20250304677A1
(en)
|
2022-07-04 |
2025-10-02 |
Vib Vzw |
Blood-Cerebrospinal Fluid Barrier Crossing Antibodies
|
|
MA71385A
(fr)
|
2022-07-08 |
2025-04-30 |
Novo Nordisk A/S |
Composés isvd hautement puissants capables de remplacer fviii(a)
|
|
US12098400B2
(en)
|
2022-07-08 |
2024-09-24 |
Novo Nordisk A/S |
Highly potent ISVD compounds capable of substituting for FVIII(A)
|
|
JP2025531719A
(ja)
|
2022-08-31 |
2025-09-25 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
鎌状赤血球症の治療のための融合ポリペプチドの投薬及び投与
|
|
US20260159606A1
(en)
|
2022-09-27 |
2026-06-11 |
Vib Vzw |
Antivirals Against Human Parainfluenza Virus
|
|
JP2025537809A
(ja)
|
2022-11-15 |
2025-11-20 |
アイメック・ヴェーゼットウェー |
液滴操作のための方法およびシステム
|
|
WO2024126805A1
(en)
|
2022-12-15 |
2024-06-20 |
Aarhus Universitet |
Synthetic activation of multimeric transmembrane receptors
|
|
EP4638735A1
(de)
|
2022-12-22 |
2025-10-29 |
Biotalys NV |
Verfahren zur genomeditierung
|
|
WO2024145551A1
(en)
|
2022-12-29 |
2024-07-04 |
Biotalys NV |
Agrochemical compositions
|
|
EP4642233A1
(de)
|
2022-12-30 |
2025-11-05 |
Biotalys NV |
Agglomerat
|
|
US20260096562A1
(en)
|
2022-12-30 |
2026-04-09 |
Biotalys NV |
Self-emulsifiable concentrate
|
|
EP4642916A2
(de)
|
2022-12-30 |
2025-11-05 |
Biotalys NV |
Sekretionssignale
|
|
JP2026519901A
(ja)
|
2023-01-27 |
2026-06-19 |
ヴィーアイビー ヴィーゼットヴィー |
Ｃｄ１６３結合複合体
|
|
US20260102527A1
(en)
|
2023-01-27 |
2026-04-16 |
Vrije Universiteit Brussel |
CD8b-BINDING POLYPEPTIDES
|
|
EP4662246A1
(de)
|
2023-02-09 |
2025-12-17 |
Seni-Preps B.V. |
Variable immunglobulin-einzeldomänen zur hemmung von urease und verwendung davon
|
|
WO2024175787A1
(en)
|
2023-02-24 |
2024-08-29 |
Vrije Universiteit Brussel |
Anti-inflammatory pannexin 1 channel inhibitors
|
|
US20240344078A1
(en)
|
2023-03-14 |
2024-10-17 |
Aarhus Universitet |
Genetically altered nfr5 receptor kinases
|
|
JP2026519919A
(ja)
|
2023-04-03 |
2026-06-19 |
ブイアイビー ブイゼットダブリュ |
血液脳関門通過抗体
|
|
EP4709753A1
(de)
|
2023-05-11 |
2026-03-18 |
Vib Vzw |
Slc4a4/nbce1-inhibitoren
|
|
WO2024240162A1
(en)
|
2023-05-23 |
2024-11-28 |
Shanghai Allygen Biologics Co., Ltd. |
Pd-l1 and trop-2 targeting conjugates comprising effector molecules and uses thereof
|
|
EP4731656A1
(de)
|
2023-06-23 |
2026-04-29 |
Vib Vzw |
Neue bindemittel gegen das gegen mehrere arzneimittel resistente pathogen acinetobacter baumannii
|
|
EP4483951A1
(de)
|
2023-06-30 |
2025-01-01 |
Université de Liège |
Einzeldomänenantikörper zur hemmung der aktivität neutrophiler elastase
|
|
EP4739706A1
(de)
|
2023-07-05 |
2026-05-13 |
CSL Innovation Pty Ltd |
Verfahren zur behandlung oder prävention einer komplikation von sichelzellanämie
|
|
WO2025034806A1
(en)
|
2023-08-08 |
2025-02-13 |
Wisconsin Alumni Research Foundation |
Single-domain antibodies and variants thereof against fibroblast activation protein
|
|
NL2036011B1
(en)
|
2023-10-12 |
2025-04-30 |
Synapse Res Institute |
Molecules for reversing anti-coagulant activity of direct oral anticoagulants
|
|
AU2024373680A1
(en)
|
2023-11-03 |
2026-06-18 |
Neuvasq Biotechnologies Sa |
Wnt7 signaling agonists
|
|
WO2025109176A1
(en)
|
2023-11-22 |
2025-05-30 |
Exevir Bio Bv |
Optimized sarbecovirus spike s2 subunit binders and compositions comprising the same
|
|
WO2025125577A1
(en)
|
2023-12-14 |
2025-06-19 |
Vib Vzw |
Antibodies against influenza b virus
|
|
WO2025133390A1
(en)
|
2023-12-22 |
2025-06-26 |
Biotalys NV |
Anti-fungal vhh antibodies
|
|
WO2025154056A1
(en)
|
2024-01-21 |
2025-07-24 |
Ibi-Ag Innovative Bio Insecticides Ltd. |
Anti-insect cda nanobodies and uses thereof
|
|
WO2025154058A1
(en)
|
2024-01-21 |
2025-07-24 |
Ibi-Ag Innovative Bio Insecticides Ltd. |
Anti-insect hsp70 nanobodies and uses thereof
|
|
WO2025181155A1
(en)
|
2024-02-26 |
2025-09-04 |
Vib Vzw |
Human beta-glucocerebrosidase binders and uses thereof
|
|
WO2025196308A1
(en)
|
2024-03-22 |
2025-09-25 |
Vib Vzw |
Means and methods for displaying fc-containing proteins on cells and selection thereof
|
|
WO2025219231A1
(en)
|
2024-04-15 |
2025-10-23 |
Vib Vzw |
Computer-implemented means and methods for the de novo design of antibodies targeting a specific epitope
|
|
WO2025238157A1
(en)
|
2024-05-15 |
2025-11-20 |
Katholieke Universiteit Leuven |
Multispecific binding agent suitable for use in cancer immune therapy
|
|
WO2026008665A1
(en)
|
2024-07-01 |
2026-01-08 |
Vib Vzw |
Binders of the pd-1•pd-l1 complex and their use
|
|
WO2026008785A1
(en)
|
2024-07-03 |
2026-01-08 |
Biotalys NV |
Agrochemical compositions
|
|
WO2026027659A1
(en)
|
2024-07-31 |
2026-02-05 |
Seni-Preps B.V. |
Improved immunoglobulin single variable domains that inhibit urease and use thereof
|
|
WO2026068859A1
(en)
|
2024-09-30 |
2026-04-02 |
Université Libre de Bruxelles |
Wnt signaling agonist molecules in the treatment of a bone-related disease or disorder
|
|
WO2026087355A1
(en)
|
2024-10-22 |
2026-04-30 |
Biotalys NV |
Downstream processing
|
|
WO2026093923A1
(en)
|
2024-10-29 |
2026-05-07 |
Csl Behring Ag |
Method for detection of a plasma protein
|
|
WO2026109764A1
(en)
|
2024-11-22 |
2026-05-28 |
Novozymes A/S |
Stabilized solid formulation of antibodies
|